CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

RNAi drug specialist ADARx raises $446M IPO

IPO/OfferingPositive
AI Analysis

Summary

ADARx, an RNAi drug specialist, raised $446M in an IPO, becoming the first RNAi biotech to price an IPO in the U.S. in over a decade and the only RNA-based drug maker to go public since 2024.

Importance:7/10
Sentiment:
0.70
IPORNAiRNA-based drugscapital raise
Related Companies

Read the original article

Published by BioPharma Dive on September 25, 2026 12:36 AM

Read Original